BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35090693)

  • 1. Amide proton transfer and chemical exchange saturation transfer MRI differentiates between growing and non-growing intracranial meningiomas: a pilot study.
    Koike H; Morikawa M; Ideguchi R; Uetani M; Hiu T; Matsuo T
    Clin Radiol; 2022 Apr; 77(4):e295-e301. PubMed ID: 35090693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Chemical Exchange Saturation Transfer Imaging of Amide Proton Transfer Differentiates between Cerebellopontine Angle Schwannoma and Meningioma: Preliminary Results.
    Koike H; Morikawa M; Ishimaru H; Ideguchi R; Uetani M; Hiu T; Matsuo T; Miyoshi M
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amide proton transfer imaging for differentiation of benign and atypical meningiomas.
    Joo B; Han K; Choi YS; Lee SK; Ahn SS; Chang JH; Kang SG; Kim SH; Zhou J
    Eur Radiol; 2018 Jan; 28(1):331-339. PubMed ID: 28687916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amide proton transfer (APT) and magnetization transfer (MT) in predicting short-term therapeutic outcome in nasopharyngeal carcinoma after chemoradiotherapy: a feasibility study of three-dimensional chemical exchange saturation transfer (CEST) MRI.
    Liu W; Wang X; Xie S; Liu WV; Masokano IB; Bai Y; Chen J; Zhong L; Luo Y; Zhou G; Li W; Pei Y
    Cancer Imaging; 2023 Sep; 23(1):80. PubMed ID: 37658446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can amide proton transfer-weighted imaging differentiate tumor grade and predict Ki-67 proliferation status of meningioma?
    Yu H; Wen X; Wu P; Chen Y; Zou T; Wang X; Jiang S; Zhou J; Wen Z
    Eur Radiol; 2019 Oct; 29(10):5298-5306. PubMed ID: 30887206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amide proton transfer MRI differentiates between progressive multifocal leukoencephalopathy and malignant brain tumors: a pilot study.
    Koike H; Morikawa M; Ishimaru H; Ideguchi R; Uetani M; Hiu T; Matsuo T; Miyoshi M
    BMC Med Imaging; 2022 Dec; 22(1):227. PubMed ID: 36572873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla.
    Jiang S; Yu H; Wang X; Lu S; Li Y; Feng L; Zhang Y; Heo HY; Lee DH; Zhou J; Wen Z
    Eur Radiol; 2016 Jan; 26(1):64-71. PubMed ID: 25925361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amide proton transfer imaging of glioblastoma, neuroblastoma, and breast cancer cells on a 11.7 T magnetic resonance imaging system.
    Tanoue M; Saito S; Takahashi Y; Araki R; Hashido T; Kioka H; Sakata Y; Yoshioka Y
    Magn Reson Imaging; 2019 Oct; 62():181-190. PubMed ID: 31302222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amid proton transfer (APT) and magnetization transfer (MT) MRI contrasts provide complimentary assessment of brain tumors similarly to proton magnetic resonance spectroscopy imaging (MRSI).
    Su C; Zhao L; Li S; Jiang J; Cai K; Shi J; Yao Y; Ao Q; Zhang G; Shen N; Hu S; Zhang J; Qin Y; Zhu W
    Eur Radiol; 2019 Mar; 29(3):1203-1210. PubMed ID: 30105412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the Role of Amide Proton Transfer (APT)-Weighted Contrast, Optimized for Normalization and Region of Interest Selection, in Differentiation of Neoplastic and Infective Mass Lesions on 3T MRI.
    Debnath A; Gupta RK; Singh A
    Mol Imaging Biol; 2020 Apr; 22(2):384-396. PubMed ID: 31228076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical Exchange Saturation Transfer MRI for Differentiating Radiation Necrosis From Tumor Progression in Brain Metastasis-Application in a Clinical Setting.
    Mehrabian H; Chan RW; Sahgal A; Chen H; Theriault A; Lam WW; Myrehaug S; Tseng CL; Husain Z; Detsky J; Soliman H; Stanisz GJ
    J Magn Reson Imaging; 2023 Jun; 57(6):1713-1725. PubMed ID: 36219521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing amide proton transfer imaging in haemorrhage brain lesions using 3T MRI.
    Jeong HK; Han K; Zhou J; Zhao Y; Choi YS; Lee SK; Ahn SS
    Eur Radiol; 2017 Apr; 27(4):1577-1584. PubMed ID: 27380905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of ischemic penumbra in patients with hyperacute stroke using amide proton transfer (APT) chemical exchange saturation transfer (CEST) MRI.
    Tietze A; Blicher J; Mikkelsen IK; Østergaard L; Strother MK; Smith SA; Donahue MJ
    NMR Biomed; 2014 Feb; 27(2):163-74. PubMed ID: 24288260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
    Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
    Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
    Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ
    J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of Meningiomas and Gliomas by Amide Proton Transfer Imaging: A Preliminary Study of Brain Tumour Infiltration.
    Zhang HW; Liu XL; Zhang HB; Li YQ; Wang YL; Feng YN; Deng K; Lei Y; Huang B; Lin F
    Front Oncol; 2022; 12():886968. PubMed ID: 35646626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume.
    Choi YS; Ahn SS; Lee SK; Chang JH; Kang SG; Kim SH; Zhou J
    Eur Radiol; 2017 Aug; 27(8):3181-3189. PubMed ID: 28116517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Early Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer Using Amide Proton Transfer-weighted Chemical Exchange Saturation Transfer MRI: A Pilot Study.
    Zhang S; Rauch GM; Adrada BE; Boge M; Mohamed RMM; Abdelhafez AH; Son JB; Sun J; Elshafeey NA; White JB; Musall BC; Miyoshi M; Wang X; Kotrotsou A; Wei P; Hwang KP; Ma J; Pagel MD
    Radiol Imaging Cancer; 2021 Sep; 3(5):e200155. PubMed ID: 34477453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades.
    Togao O; Yoshiura T; Keupp J; Hiwatashi A; Yamashita K; Kikuchi K; Suzuki Y; Suzuki SO; Iwaki T; Hata N; Mizoguchi M; Yoshimoto K; Sagiyama K; Takahashi M; Honda H
    Neuro Oncol; 2014 Mar; 16(3):441-8. PubMed ID: 24305718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CEST 2022-three-dimensional amide proton transfer (APT) imaging can identify the changes of cerebral cortex in Parkinson's disease.
    Tian Y; Li X; Wang X; Su W; Li S; Wang W; Zhang Y; Li C; Chen M
    Magn Reson Imaging; 2023 Oct; 102():235-241. PubMed ID: 37356600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.